Long-term effects of aminoguanidine on insulin release and biosynthesis: evidence that the formation of advanced glycosylation end products inhibits B cell function - PubMed (original) (raw)
Long-term effects of aminoguanidine on insulin release and biosynthesis: evidence that the formation of advanced glycosylation end products inhibits B cell function
Y Tajiri et al. Endocrinology. 1997 Jan.
Abstract
Chronic hyperglycemia has adverse effects on B cell function. We investigated the possible role of advanced glycosylation end products (AGEs) in glucotoxicity. Rat islets were cultured at different glucose concentrations for 1-6 weeks in RPMI 1640. Culture was performed with or without aminoguanidine (AG), which is known to prevent AGE formation in other tissues. AGE-associated fluorescence (370 nm excitation and 440 nm emission) progressively increased during 6 weeks of culture at 38 nM, but not at 11 or 5.5 mM, glucose. The increase in fluorescence was significantly inhibited by AG. The effects of AG on insulin secretion were tested directly after the culture period as well as after a wash-out period of continued culture at 11 mM glucose in the absence of AG. The presence of AG during culture for 1 week at 38 mM glucose failed to affect basal release at 3.3 mM glucose or stimulated release at 27 mM glucose. AG was ineffective whether tested directly after the culture period or after wash-out. When the same culture conditions were prolonged for 6 weeks, culture with AG suppressed basal and stimulated insulin secretion after the culture period. However, after wash-out, previous AG treatment enhanced the insulin response to 27 mM glucose 2-fold compared to culture without AG (P < 0.01). Proinsulin and total protein biosyntheses in 38 mM glucose-cultured islets were increased 40-80% by AG after 6 weeks of culture, and this effect was similar after wash-out. Preproinsulin messenger RNA levels were significantly increased (P < 0.05) after 6 weeks of culture with AG. NG-Methyl-L-arginine, a nitric oxide synthase inhibitor, failed to mimic the effects of AG. The results indicate that the time-dependent beneficial effects of AG on insulin secretion and biosynthesis are related to inhibitory effects on AGE formation and that accumulation of islet AGEs could be important for glucotoxicity toward B cells.
Similar articles
- Aminoguanidine exerts a beta-cell function-preserving effect in high glucose-cultured beta-cells (INS-1).
Tajiri Y, Grill V. Tajiri Y, et al. Int J Exp Diabetes Res. 2000;1(2):111-9. doi: 10.1155/edr.2000.111. Int J Exp Diabetes Res. 2000. PMID: 11469395 Free PMC article. - Improvement by aminoguanidine of insulin secretion from pancreatic islets grafted to syngeneic diabetic rats.
Hiramatsu S, Inoue K, Tajirl Y, Grill V. Hiramatsu S, et al. Biochem Pharmacol. 2000 Jul 15;60(2):263-8. doi: 10.1016/s0006-2952(00)00318-x. Biochem Pharmacol. 2000. PMID: 10825471 - Effects of aminoguanidine on insulin release from pancreatic islets.
Tasaka Y, Nakaya F, Matsumoto H, Omori Y. Tasaka Y, et al. Endocr J. 1994 Jun;41(3):309-13. doi: 10.1507/endocrj.41.309. Endocr J. 1994. PMID: 7951584 - Interactions between vitamin E and glucose on B-cell functions in the rat: an in vivo and in vitro study.
Tajiri Y, Grill VE. Tajiri Y, et al. Pancreas. 1999 Apr;18(3):274-81. doi: 10.1097/00006676-199904000-00009. Pancreas. 1999. PMID: 10206486 - High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction.
Kooptiwut S, Kebede M, Zraika S, Visinoni S, Aston-Mourney K, Favaloro J, Tikellis C, Thomas MC, Forbes JM, Cooper ME, Dunlop M, Proietto J, Andrikopoulos S. Kooptiwut S, et al. J Mol Endocrinol. 2005 Aug;35(1):39-48. doi: 10.1677/jme.1.01720. J Mol Endocrinol. 2005. PMID: 16087720
Cited by
- Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus.
Tangvarasittichai S. Tangvarasittichai S. World J Diabetes. 2015 Apr 15;6(3):456-80. doi: 10.4239/wjd.v6.i3.456. World J Diabetes. 2015. PMID: 25897356 Free PMC article. Review. - Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants.
Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP. Tanaka Y, et al. Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10857-62. doi: 10.1073/pnas.96.19.10857. Proc Natl Acad Sci U S A. 1999. PMID: 10485916 Free PMC article. - Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat.
Yue Y, Yeh JN, Chiang JY, Sung PH, Chen YL, Liu F, Yip HK. Yue Y, et al. Stem Cell Res Ther. 2022 May 7;13(1):186. doi: 10.1186/s13287-022-02857-5. Stem Cell Res Ther. 2022. PMID: 35526048 Free PMC article. - HIF-2α Preserves Mitochondrial Activity and Glucose Sensing in Compensating β-Cells in Obesity.
Moon JS, Riopel M, Seo JB, Herrero-Aguayo V, Isaac R, Lee YS. Moon JS, et al. Diabetes. 2022 Jul 1;71(7):1508-1524. doi: 10.2337/db21-0736. Diabetes. 2022. PMID: 35472707 Free PMC article. - Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.
Arakawa K, Ishihara T, Oku A, Nawano M, Ueta K, Kitamura K, Matsumoto M, Saito A. Arakawa K, et al. Br J Pharmacol. 2001 Jan;132(2):578-86. doi: 10.1038/sj.bjp.0703829. Br J Pharmacol. 2001. PMID: 11159708 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical